Extending the benefit of Avastin: combination with other anticancer agents in NSCLC
- An extensive clinical trial programme is underway for Avastin in NSCLC to
- further expand the proven first-line efficacy of Avastin
- evaluate Avastin in combination with different chemotherapy regimens, including pemetrexed and other targeted agents (e.g. Tarceva).
- Disclaimer: Avastin.net is a comprehensive resource for healthcare professionals outside the US. If you are a US resident please visit www.avastin.comThe information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.